Regarding the treatment for SSc at the time of AMH measurement: n = 9 (30%) of the patients were taking low-dose prednisone (i.e. ≤ 5mg prednisone per day), n = 8 (27%) MTX, n = 6 (20%) MMF, n = 3 (10%) AZA and n = 5 (17%) bosentan. This evidence concerns the gene AMH and systemic sclerosis.